KING INTL INV0928.HKValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Richly Valued” zone.
As of Oct 16, 2026, KING INTL INV (0928.HK) trades at a P/E of 241.00x, P/B of 1.87x, P/S of 3.10x, and a dividend yield of 0.00%.
Longitudinal percentile comparison: P/E sits at the 98th percentile over the trailing 10Y window (vs. 98th percentile over 3Y); P/B sits at the 78th percentile over the trailing 10Y window (vs. 99th percentile over 3Y); P/S sits at the 62nd percentile over the trailing 10Y window (vs. 86th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 96th percentile within its industry and the 98th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 0.00%; its historical percentile over the trailing long-term window is still accumulating data.
The P/E and P/B percentiles diverge here, differing by 19.7 points — relying on either metric alone could be misleading. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. KING INTL INV operates in the Other Pharmaceuticals and Medical Services sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: HKG: 0928 · SEHK: 0928 · 0928
Want the full picture on whether KING INTL INV (0928.HK) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 241.00 | ||||||
| P/B (MRQ) | 1.87 | ||||||
| P/S (TTM) | 3.10 | ||||||
| Dividend Yield | 0.00% | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback + Div Yield | 0.00% | 0 | 0 | 0 | 0 | 0 | 0 |